Ensysce Biosciences, Inc.
ENSC
$0.47
$0.000.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.62M | -11.79M | -10.18M | -10.97M | -6.58M |
| Total Depreciation and Amortization | 19.50K | 13.00K | 6.50K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 1.20M | 804.00K | 847.60K | 453.30K | 373.10K |
| Change in Net Operating Assets | 2.55M | 1.37M | 1.52M | 3.47M | 9.80K |
| Cash from Operations | -8.86M | -9.60M | -7.81M | -7.04M | -6.20M |
| Capital Expenditure | -123.60K | -123.60K | -123.60K | -123.60K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -123.60K | -123.60K | -123.60K | -123.60K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -208.90K | -233.00K | -216.30K | -207.60K | -239.00K |
| Issuance of Common Stock | 2.18M | 2.22M | 3.67M | 3.35M | 3.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 5.98M | 3.98M | 3.98M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -503.10K | 1.45M | 1.31M | 1.55M | 4.09M |
| Cash from Financing | 7.44M | 7.42M | 8.74M | 4.69M | 7.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.54M | -2.31M | 808.20K | -2.48M | 1.17M |